These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8343943)

  • 21. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive therapy in diabetes.
    Hostetter TH
    Am J Kidney Dis; 1989 Jun; 13(6 Suppl 1):13-6. PubMed ID: 2735323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril in treatment of hypertensive diabetic patients. Preliminary study.
    Christov V; Nikolov M; Popova D; Suzuki A; Nikolov N
    Agressologie; 1989 Feb; 30(2):103-5. PubMed ID: 2660616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy.
    Roozbeh J; Banihashemi MA; Ghezlou M; Afshariani R; Salari S; Moini M; Sagheb MM
    Ren Fail; 2010 Jan; 32(2):172-8. PubMed ID: 20199178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril in the treatment of hypertension in type I and type II diabetic patients.
    Gambaro G; Morbiato F; Cicerello E; Del Turco M; Sartori L; D'Angelo A; Crepaldi G
    J Hypertens Suppl; 1985 Nov; 3(2):S149-51. PubMed ID: 3910773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the reno-protective effect of short- and long-acting antihypertensive agents in IgA nephropathy].
    Vas T; Kovács T; Szelestei T; Csiky B; Nagy J
    Orv Hetil; 1999 Sep; 140(36):1991-5. PubMed ID: 10506823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes.
    Solerte SB; Fioravanti M
    Clin Nephrol; 1987 Sep; 28(3):138-43. PubMed ID: 3665207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
    Hopper AH; Tindall H; Davies JA
    Nephrol Dial Transplant; 1989; 4(2):140-3. PubMed ID: 2496357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril in the treatment of hypertension in type I and type II diabetic patients.
    D'Angelo A; Sartori L; Gambaro G; Giannini S; Malvasi L; Benetollo P; Lavagnini T; Crepaldi G
    Postgrad Med J; 1986; 62 Suppl 1():69-72. PubMed ID: 3534866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
    Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
    Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of felodipine in patients with reduced renal function.
    Herlitz H
    Kidney Int Suppl; 1992 May; 36():S110-3. PubMed ID: 1614060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion.
    De Cosmo S; Earle K; Morocutti A; Walker J; Ruggenenti P; Remuzzi G; Viberti GC
    Diabetologia; 1993 Jul; 36(7):622-7. PubMed ID: 8359579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
    Holländer E
    Orv Hetil; 1987 Apr; 128(17):893-5. PubMed ID: 3295665
    [No Abstract]   [Full Text] [Related]  

  • 36. Captopril in hypertension after renal transplantation.
    Herlitz H; Ahlmén J; Aurell M; Blohmé I; Brynger H; Delin K; Larsson O
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy.
    Pistrosch F; Passauer J; Herbrig K; Schwanebeck U; Gross P; Bornstein SR
    Horm Metab Res; 2012 Nov; 44(12):914-8. PubMed ID: 22723267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of cyclosporin A on blood pressure and renal hemodynamics in insulin dependent diabetes].
    Hannedouche T; Delgado A; Gnionsahe A; Boitard C; Lacour B; Grünfeld JP
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():221-3. PubMed ID: 3142410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
    Parving HH; Hommel E; Smidt UM
    BMJ; 1988 Oct; 297(6656):1086-91. PubMed ID: 3143437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.
    Valvo E; Bedogna V; Casagrande P; Antiga L; Zamboni M; Bommartini F; Oldrizzi L; Rugiu C; Maschio G
    Am J Med; 1988 Sep; 85(3):344-8. PubMed ID: 3046353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.